• Aucun résultat trouvé

GRADE table: Electronic reminders for promoting adherence to ART among people living with HIV – Randomized Controlled Trials

N/A
N/A
Protected

Academic year: 2022

Partager "GRADE table: Electronic reminders for promoting adherence to ART among people living with HIV – Randomized Controlled Trials "

Copied!
3
0
0

Texte intégral

(1)

WHO/HIV/2013.69 © World Health Organization 2013

This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group on HIV/AIDS 1

GRADE table: Electronic reminders for promoting adherence to ART among people living with HIV – Randomized Controlled Trials

Author(s): Horvath T Date: 2012-10-08

Question: Should mobile phone text messages be used for promoting adherence to antiretroviral therapy in patients with HIV infection?

Settings: Brazil, Cameroon, Guatemala, Kenya, Peru

Bibliography: Lester 2010, Pop-Eleches 2011, Curioso 2012, da Costa 2012, Ikeda 2012, Mbuagbaw 2012

Quality assessment No. of patients Effect

Quality Importance

No. of

studies Design Risk of

bias Inconsistency Indirectness Imprecision Other considerations

Mobile phone

text messages Control Relative

(95% CI) Absolute

Viral load suppression at 52 weeks: any text messages versus standard care

2 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

no serious imprecision

none 246/391

(62.9%)

165/373 (44.2%)

RR 0.67 (0.57 to 0.78)

146 fewer per 1000 (from 97 fewer to 190

fewer)

⊕⊕⊕⊕

HIGH

CRITICAL

Viral load suppression at 52 weeks: weekly text messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

no serious imprecision

none 156/273

(57.1%)

128/265 (48.3%)

RR 0.83 (0.69 to 0.99)

82 fewer per 1000 (from 5 fewer to 150 fewer)

⊕⊕⊕⊕

HIGH

CRITICAL

Viral load suppression at 52 weeks: daily text messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

serious1 none 90/118

(76.3%)

37/108 (34.3%)

RR 0.36 (0.25 to 0.51)

219 fewer per 1000 (from 168 fewer to 257

fewer)

⊕⊕⊕O MODERATE

CRITICAL

Viral load suppression at 30 weeks: daily text messages versus standard care

1 randomized trials

no serious risk of bias

no serious inconsistency

no serious indirectness

serious1 none 74/118

(62.7%)

32/108 (29.6%)

RR 0.53 (0.41 to 0.69)

139 fewer per 1000 (from 92 fewer to 175

fewer)

⊕⊕⊕O MODERATE

CRITICAL

ART adherence at 48–52 weeks: any text messages versus standard care (overall)

(2)

WHO/HIV/2013.69 © World Health Organization 2013

This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group on HIV/AIDS 2

3 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

no serious imprecision

none 340/649

(52.4%)

201/491 (40.9%)

RR 0.79 (0.71 to 0.88)

86 fewer per 1000 (from 49 fewer to 119 fewer)

⊕⊕⊕⊕

HIGH

CRITICAL

ART adherence at 48–52 weeks: weekly text messages versus standard care (overall)

2 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

no serious imprecision

none 285/494

(57.7%)

188/404 (46.5%)

RR 0.78 (0.68 to 0.89)

102 fewer per 1000 (from 51 fewer to 149

fewer)

⊕⊕⊕⊕

HIGH

CRITICAL

ART adherence at 48–52 weeks: short weekly messages versus standard care

2 randomized trials

no serious risk of bias

no serious inconsistency

no serious indirectness

no serious imprecision

none 207/346

(59.8%)

188/404 (46.5%)

RR 0.77 (0.66 to 0.9)

107 fewer per 1000 (from 47 fewer to 158

fewer)

⊕⊕⊕⊕

HIGH

CRITICAL

ART adherence at 48 weeks: long weekly messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

very serious2 none 39/74

(52.7%)

56/139 (40.3%)

RR 0.79 (0.6 to 1.04)

85 fewer per 1000 (from 161 fewer to 16 more)

⊕⊕OO LOW

CRITICAL

ART adherence at 48 weeks: short daily messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

very serious2 none 28/70

(40%)

56/139 (40.3%)

RR 1 (0.79 to 1.27)

0 fewer per 1000 (from 85 fewer to 109 more)

⊕⊕OO LOW

CRITICAL

ART adherence at 48 weeks: long daily messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

very serious2 none 30/72

(41.7%)

56/139 (40.3%)

RR 0.98 (0.77 to 1.24)

8 fewer per 1000 (from 93 fewer to 97 more)

⊕⊕OO LOW

CRITICAL

ART adherence at 26 weeks: short weekly text messages versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

serious1 none 80/101

(79.2%)

78/99 (78.8%)

RR 0.98 (0.57 to 1.68)

16 fewer per 1000 (from 339 fewer to 536 more)

⊕⊕⊕O MODERATE

CRITICAL

ART adherence at 52 weeks: flexible number and interval of messages versus standard care

(3)

WHO/HIV/2013.69 © World Health Organization 2013

This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group on HIV/AIDS 3

1 randomized

trials

no serious risk of bias

no serious inconsistency

serious3 very serious2 none 36/87

(41.4%)

13/87 (14.9%)

RR 0.69 (0.57 to 0.84)

46 fewer per 1000 (from 24 fewer to 64 fewer)

⊕OOO VERY LOW

CRITICAL

ART adherence at 16 weeks: text messages five times per week versus standard care

1 randomized

trials

no serious risk of bias

no serious inconsistency

no serious indirectness

very serious2 none 6/8

(75%)

6/13 (46.2%)

RR 0.46 (0.13 to 1.71)

249 fewer per 1000 (from 402 fewer to 328

more)

⊕⊕OO LOW

CRITICAL

Pharmacy refill data at 26 weeks: short weekly messages versus standard care (better indicated by lower values)

1 randomized trials

no serious risk of bias

no serious inconsistency

no serious indirectness

serious1 none 101 99 - Mean difference 0.1

higher (0.29 lower to 0.49 higher)

⊕⊕⊕O MODERATE

IMPORTANT

1 Few events.

2 Very few events.

3 Self-reported adherence.

Références

Documents relatifs

Collaboration has focused on the system- atic electronic searching of MEDLINE and EMBASE and the systematic hand- searching of currently over 2000 general and specialized health

• In one trial (Pop-Eleches 2011) with 48 weeks of follow-up, patients who received short daily mobile phone text messages were at no different risk of being

9Practical example: price and eligibility of three products from three different companies in four countries 11Tables 11 Table 1: Summary of best ARV price offers by

This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group on HIV/AIDS.. GRADE

This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group on HIV/AIDS.. 1 GRADE

31 Oct 2012 PICO a - This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group

31 Oct 2012 PICO b - This work was commissioned by the World Health Organization and carried out by The University of California, San Francisco (UCSF), Cochrane Review Group

These principles have been the foundation for an integrated provision of services including: (1) voluntary confi dential counseling and testing (VCCT) services, linking